PULMONARY RENAL SYNDROME

PULMONARY RENAL SYNDROME was reported 349 times

PULMONARY RENAL SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Humanized Monoclonal Antibody Fragment [EPC] 3 0.0021
1 Thyroid Hormone Synthesis Inhibitor [EPC] 7 0.0007
2 Vitamin D3 Analog [EPC] 11 0.0005
3 Cephalosporin Antibacterial [EPC] 3 0.0003
4 Complement 5a Receptor Antagonist [EPC] 2 0.0003
5 gamma-Aminobutyric Acid-ergic Agonist [EPC] 18 0.0002
6 alpha-Adrenergic Blocker [EPC] 27 0.0002
7 Central alpha-2 Adrenergic Agonist [EPC] 10 0.0002
8 Muscle Relaxant [EPC] 8 0.0002
9 Dihydropyridine Calcium Channel Blocker [EPC] 54 0.0002
10 Thrombopoietin Receptor Agonist [EPC] 2 0.0001
11 Echinocandin Antifungal [EPC] 1 0.0001
12 Penem Antibacterial [EPC] 4 0.0001
13 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
14 Calcitonin Gene-related Peptide Antagonist [EPC] 1 0.0001
15 Leukotriene Receptor Antagonist [EPC] 3 0.0001
16 Human Immunoglobulin G [EPC] 2 0.0001
17 Antimetabolite Immunosuppressant [EPC] 2 0.0001
18 beta-Adrenergic Blocker [EPC] 27 0.0001
19 Histamine-1 Receptor Antagonist [EPC] 7 0.0001
20 Parenteral Iron Replacement [EPC] 1 0.0001
21 Aldosterone Antagonist [EPC] 11 0.0001
22 Fluoroquinolone Antibacterial [EPC] 9 0.0001
23 Factor Xa Inhibitor [EPC] 17 0.0001
24 Platelet Aggregation Inhibitor [EPC] 33 0.0001
25 Alkylating Drug [EPC] 12 0.0000
26 Loop Diuretic [EPC] 22 0.0000
27 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
28 Aromatase Inhibitor [EPC] 5 0.0000
29 Bile Acid [EPC] 1 0.0000
30 Insulin [EPC] 2 0.0000
31 Xanthine Oxidase Inhibitor [EPC] 7 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 12 0.0000
33 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
34 Angiotensin 2 Receptor Blocker [EPC] 11 0.0000
35 Nitrate Vasodilator [EPC] 3 0.0000
36 Insulin Analog [EPC] 14 0.0000
37 Glycopeptide Antibacterial [EPC] 2 0.0000
38 Nonsteroidal Anti-inflammatory Drug [EPC] 39 0.0000
39 HMG-CoA Reductase Inhibitor [EPC] 11 0.0000
40 Tetracycline-class Drug [EPC] 2 0.0000
41 P2Y12 Platelet Inhibitor [EPC] 3 0.0000
42 Aminoglycoside Antibacterial [EPC] 1 0.0000
43 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
44 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
45 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
46 Retinoid [EPC] 5 0.0000
47 Corticosteroid [EPC] 26 0.0000
48 Microtubule Inhibitor [EPC] 3 0.0000
49 Proton Pump Inhibitor [EPC] 9 0.0000
50 Nitroimidazole Antimicrobial [EPC] 1 0.0000
51 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
52 Platinum-based Drug [EPC] 4 0.0000
53 HER2/neu Receptor Antagonist [EPC] 1 0.0000
54 Topoisomerase Inhibitor [EPC] 1 0.0000
55 Nucleoside Analog Antiviral [EPC] 1 0.0000
56 Anti-IgE [EPC] 1 0.0000
57 Purine Antimetabolite [EPC] 1 0.0000
58 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
59 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
60 Benzodiazepine [EPC] 5 0.0000
61 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
62 Janus Kinase Inhibitor [EPC] 1 0.0000
63 RANK Ligand Inhibitor [EPC] 1 0.0000
64 Thiazide Diuretic [EPC] 1 0.0000
65 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
66 Kinase Inhibitor [EPC] 2 0.0000
67 Osmotic Laxative [EPC] 1 0.0000
68 Vitamin D [EPC] 1 0.0000
69 Vitamin B12 [EPC] 1 0.0000
70 Vitamin C [EPC] 1 0.0000
71 GLP-1 Receptor Agonist [EPC] 1 0.0000
72 Tumor Necrosis Factor Blocker [EPC] 2 0.0000